Archives: Agenda

• Looking at why Europe is losing competitiveness and risks falling behind in trial attractiveness and patient access despite advanced healthcare systems and strong research reputations
• What must change for Europe to remain desirable, including initiatives shaping the future European landscape (FAST‑EU, COMBINE, EU Biotech Act)
• Examining the rise of emerging trial destinations, from China to the Middle East, alongside the ethical responsibilities and more favourable regulatory approvals
• Exploring the role of ISO 18969 in harmonising clinical investigation processes and supporting more efficient trial delivery across Europe

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!

• Understanding the link between European competitiveness, trial attractiveness, and patient access
• Examining how site capacity constraints are reshaping the clinical trial landscape
• Exploring what differentiates sponsors that sites and patients actively choose to work with
• Assessing how trusted partnerships can accelerate study delivery and bring innovation to patients faster

• Understanding the evidence and recommendations for meaningful Patient Research Partner (PRP) involvement in clinical research: Review the 2023 EULAR recommendations and explore why involving PRPs from the inception of a research programme can improve the relevance, feasibility and quality of clinical development.
• Recognising the impact of early patient partnership on clinical trial success: Examine how PRP involvement can influence protocol design, patient burden, recruitment, retention, study execution and ultimately support regulatory decision-making and approval readiness.
• Identifying practical approaches to implementation and measurement: Discuss how sponsors, CROs and research teams can operationalise PRP involvement throughout outsourced clinical development programmes, assess current levels of adoption, and measure the value and impact of patient partnership.

• How should clinical trial sponsors allocate resources to accelerate clinical development without compromising quality?
• Making strategic investment decisions across people, technology, quality and partnerships
• Deciding where to build internal capabilities versus leveraging external partners
• Balancing speed, quality and capital efficiency while preparing for the next stage of growth

• Demonstrating how SharePoint can evolve into an intelligent collaboration and knowledge-sharing ecosystem through AI agents and automation
• Showcasing practical applications including automated content classification, intelligent search, chatbots, and workflow automation
• Identifying how AI-enabled knowledge systems can improve information accessibility, collaboration, decision-making, and organisational agility while reducing inefficiencies and knowledge silos across teams

• Why faster development timelines are colliding with increasing trial complexity
• Understanding how accelerated pathways are reshaping expectations across sponsors, CROs and regulators
• Assessing whether traditional operating and outsourcing models can keep pace with today’s demands
• Adapting to rolling submissions, real-time oversight and compressed development timelines
• Building operational resilience without compromising speed, quality or compliance